VIELA BIO INC has a total of 36 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2007. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ESBATECH A NOVARTIS CO LLC, EVEC INC and CEPHALON AUSTRALIA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | Singapore | 3 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Chile | 1 | |
#12 | China | 1 | |
#13 | Hungary | 1 | |
#14 | Serbia | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Herbst Ronald | 9 |
#2 | Coyle Anthony | 9 |
#3 | Hansen Anna | 8 |
#4 | Ettinger Rachel | 8 |
#5 | Pavlik Peter | 8 |
#6 | Chen Yan | 8 |
#7 | Xiao Xiaodong | 7 |
#8 | Vousden Katherine Ann | 7 |
#9 | Oganesyan Vaheh | 6 |
#10 | Grinberg Luba | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020219743A2 | Use of an anti-cd19 antibody to treat autoimmune disease | |
CA3114394A1 | Cd40l antagonist and uses thereof | |
SG11202007702UA | Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases | |
AU2007294575A1 | Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |